- Home
- IMNM vs MQY Comparison
IMNM vs MQY Comparison
Compare IMNM & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- MQY
- Stock Information
- Founded
- IMNM 2006
- MQY 1994
- Country
- IMNM United States
- MQY United States
- Employees
- IMNM N/A
- MQY N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- MQY Investment Bankers/Brokers/Service
- Sector
- IMNM Health Care
- MQY Finance
- Exchange
- IMNM Nasdaq
- MQY Nasdaq
- Market Cap
- IMNM 945.8M
- MQY 776.5M
- IPO Year
- IMNM 2020
- MQY N/A
- Fundamental
- Price
- IMNM $10.30
- MQY $10.95
- Analyst Decision
- IMNM Strong Buy
- MQY
- Analyst Count
- IMNM 7
- MQY 0
- Target Price
- IMNM $24.57
- MQY N/A
- AVG Volume (30 Days)
- IMNM 629.1K
- MQY 184.8K
- Earning Date
- IMNM 08-06-2025
- MQY 01-01-0001
- Dividend Yield
- IMNM N/A
- MQY 4.73%
- EPS Growth
- IMNM N/A
- MQY N/A
- EPS
- IMNM N/A
- MQY N/A
- Revenue
- IMNM $12,589,000.00
- MQY N/A
- Revenue This Year
- IMNM N/A
- MQY N/A
- Revenue Next Year
- IMNM $154.73
- MQY N/A
- P/E Ratio
- IMNM N/A
- MQY N/A
- Revenue Growth
- IMNM 16.74
- MQY N/A
- 52 Week Low
- IMNM $5.15
- MQY $9.82
- 52 Week High
- IMNM $16.73
- MQY $12.52
- Technical
- Relative Strength Index (RSI)
- IMNM 53.80
- MQY 45.95
- Support Level
- IMNM $9.37
- MQY $10.85
- Resistance Level
- IMNM $10.39
- MQY $11.24
- Average True Range (ATR)
- IMNM 0.49
- MQY 0.10
- MACD
- IMNM -0.06
- MQY -0.02
- Stochastic Oscillator
- IMNM 52.81
- MQY 24.36
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About MQY Blackrock MuniYield Quality Fund Inc.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.